Showing 117 of 117on this page. Filters & sort apply to loaded results; URL updates for sharing.117 of 117 on this page
Filspari (Sparsentan) Rare Kidney Disease Drug Gets FDA Approval - Xtalks
FILSPARI Resources | FILSPARI® (sparsentan)
Filspari (sparsentan): Uses, Side Effects, Dosage & Reviews
FILSPARI (sparsentan) Tablets Supplier Cost Price In India
FILSPARI 400 mg Filmtabletten 30 St mit dem E-Rezept kaufen - Shop Apotheke
Filspari Sparsentan Tablets at ₹ 94000/bottle | Pharma Tablets in ...
FILSPARI (Sparsentan): Indications, Dose, MOA, Side Effects
Filspari « New Drug Approvals
Travere Therapeutics Announces Full FDA Approval of FILSPARI ...
FDA Grants Accelerated Approval to Filspari (sparsentan) for the ...
Filspari (sparsentan): Uses, Side Effects, Interactions, Pictures ...
Travere Therapeutics Announces FDA Acceptance of sNDA for FILSPARI ...
Filspari (sparsentan，司帕生坦)用途_治疗_蛋白尿_疗效
Filspari 2026 Prices, Coupons & Savings Tips - GoodRx
Travere Therapeutics’ Filspari (sparsentan) Receives the US FDA’s Full ...
Travere Therapeutics Advances FILSPARI (sparsentan) in FSGS and IgA ...
How to Get Filspari (Sparsentan) Covered by UnitedHealthcare in Ohio ...
Travere Therapeutics’ Filspari Receives Full FDA Approval | PharmExec
Travere's REMS modification for Filspari gets nod from FDA
Travere Therapeutics Shares Fall After FDA Extends Filspari Review for FSGS
NICE (UK) positive update for Filspari (sparsentan) for treating ...
Filspari - Cerca un farmaco
FDA approves REMS modification for Filspari (sparsentan) in IgA ...
Filspari 200 mg oral tablet at ₹ 38900/box | Lansoprazole Orally ...
FDA Approves Filspari for IgA Nephropathy
FILSPARI- sparsentan tablet, film coated
Sparsentan|Filspari®|17|2024 | PZ – Pharmazeutische Zeitung
FILSPARI-SPARSENTAN-司帕生坦片 – Globalpharma
唯一一种显著减缓IgA肾病肾功能衰退的非免疫抑制治疗药物FILSPARI获FDA全面批准-上市-医保-临床适应症-香港济民药业
Videos & Resources | FILSPARI® (sparsentan)
FDA OKs Sparsentan for IgA Nephropathy-Related Proteinuria | MedPage Today
Sparsentan: Para qué sirve, Dosis y Efectos Secundarios
First FDA-Approved FSGS Drug: Sparsentan (Filspari) Overview ...
第二种降低IgA肾病蛋白尿新药！FDA加速批准sparsentan__财经头条
Sparsentan: Uses, Dosage, Side Effects, Warnings - Drugs.com
Filspari: Package Insert - Drugs.com
【斯帕森坦,司帕生坦,斯巴生坦,Filspari,sparsentan,LuciSeta】说明书_代购价格_印度直邮-印度全球药房
These highlights do not include all the information needed to use ...
Filspari(sparsentan)中文说明书-价格-适应症-不良反应及注意事项-香港济民药业
England's NICE recommends FILSPARI® (sparsentan) as a treatment option ...
Filspari(sparsentan,司帕生坦片)中文说明书|用于原发性IgAN成人的蛋白尿治疗 | 香港致泰药业
FDA Accepts Sparsentan (Filspari) sNDA for Focal Segmental ...
DailyMed - FILSPARI- sparsentan tablet, film coated
FDA Approves REMS Label Update for Sparsentan (Filspari) in IgA ...
England's NICE recommends FILSPARI® (sparsentan) as a…
Filspari(Sparsentan):Usage,Administration
司帕生坦(Filspari)中文说明书_司帕生坦适应症_价格_用法用量_药队长
Another step forward for our longtime partner Travere Therapeutics ...
Bouncing Back From Trial Failure, Travere Wins First FDA Approval in ...
TVTX, LGND Stocks In Spotlight Ahead Of Monday’s FDA Call On Kidney ...
Ligand Partner Travere Therapeutics Receives Full FDA Approval for ...
CSL Vifor and Travere Therapeutics announce standard EU approval for ...
Travere Therapeutics Provides Update on FDA Advisory Committee Meeting ...
什么是Filspari （sparsentan）？-【医康行】
Interim Analysis of the Phase 3 PROTECT Study of FILSPARI™ (Sparsentan ...
Filspari® | Vifor Pharma Pro
Treatment Options | IgA Nephropathy Foundation
Our Therapies | Travere
非免疫抑制口服药物FILSPARI在美申报用于治疗局灶节段性肾小球硬化 - 知乎
Travere Therapeutics to Present New FILSPARI® (sparsentan) Data at the ...
Travere undercuts key rival in rare kidney disease IgAN | pharmaphorum
